Synergy CHC Corp.
corporate_fare Company Profile
Synergy CHC Corp. (NASDAQ:SNYR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 19 items for SNYR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-16, rated 9/10. Across its 19 most recent items scored 7 or higher, the top rating is 10/10, with 19 rated 8 or above. Recent SEC coverage for SNYR spans 8-K, S-1, 10-Q, PRE 14A.
Recent high-impact activity:
- Nasdaq to Suspend Synergy CHC Trading September 18 After Bankruptcy Delisting
- Synergy CHC Files Chapter 11, Plans Liquidation or Reorganization Within 120 Days
- Synergy CHC Files Chapter 11; Board Collapses to a Single Director
- Lenders Accelerate Synergy CHC's $18.9M Term Loan After Default
- Synergy CHC Faces Nasdaq Delisting Notice Over Late Q2 10-Q
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for SNYR, detected from its recent SEC filings · based on capital-structure filings through 2026-05-15.
Registration of 101.7 Million Shares for Resale · Equity Line of Credit (ELOC) Details
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →